ASLAN Pharmaceuticals Ltd. Debt to Equity Ratio 2018-2024 | ASLN
Current and historical debt to equity ratio values for ASLAN Pharmaceuticals Ltd. (ASLN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ASLAN Pharmaceuticals Ltd. debt/equity for the three months ending March 31, 2024 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-03-31 |
$0.04B |
$-0.02B |
-2.17 |
2023-12-31 |
$0.04B |
$-0.01B |
-2.85 |
2023-09-30 |
$0.05B |
$-0.00B |
-51.62 |
2023-06-30 |
$0.05B |
$0.01B |
7.67 |
2023-03-31 |
$0.05B |
$0.01B |
5.10 |
2022-12-31 |
$0.05B |
$0.01B |
6.31 |
2022-09-30 |
$0.05B |
$0.02B |
2.29 |
2022-06-30 |
$0.05B |
$0.03B |
1.47 |
2022-03-31 |
$0.05B |
$0.05B |
1.02 |
2021-12-31 |
$0.04B |
$0.06B |
0.65 |
2021-09-30 |
$0.04B |
$0.07B |
0.54 |
2021-06-30 |
$0.00B |
|
0.00 |
2021-03-31 |
$0.02B |
$0.08B |
0.26 |
2020-12-31 |
$0.03B |
$-0.01B |
-2.58 |
2020-09-30 |
$0.03B |
$-0.01B |
-2.15 |
2020-06-30 |
$0.02B |
$-0.01B |
-2.87 |
2020-03-31 |
$0.02B |
$-0.00B |
-5.66 |
2019-12-31 |
$0.02B |
$-0.00B |
-39.70 |
2019-09-30 |
$0.00B |
|
0.00 |
2019-06-30 |
$0.00B |
|
0.00 |
2019-03-31 |
$0.02B |
$0.03B |
0.78 |
2018-12-31 |
$0.02B |
$0.03B |
0.73 |
2018-09-30 |
$0.02B |
$0.04B |
0.41 |
2018-06-30 |
$0.02B |
$0.05B |
0.30 |
2018-03-31 |
$0.03B |
$0.03B |
0.94 |
2017-12-31 |
$0.02B |
$0.04B |
0.45 |
2017-09-30 |
$0.01B |
$0.05B |
0.23 |
2017-06-30 |
$0.01B |
$0.06B |
0.22 |
2017-03-31 |
$0.01B |
$0.03B |
0.39 |